Published in Cancer Weekly, July 5th, 2005
IDM is the first private company in France to receive this designation, which authorizes the company to perform activities in the preparation, storage, distribution and transfer of cell therapy products. It was granted for a renewable period of 5 years.
This designation ensures patients and the health authorities of European...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly